The AFP model exhibited better predictive performance in post-LT tumor recurrence than the Milan criteria in hepatitis C virus-related HCC patients and has been applied to select HCC candidates for LT by the Liver Transplantation French Study Group for organ sharing12. This evidence concerns the gene AFP and neoplasm.